Two UT MD Anderson researchers elected AAAS Fellows
In recognition of their significant achievements to advance cancer care and research, Theresa Guise, M.D., and Stephanie S. Watowich, Ph.D., from The University of Texas MD Anderson Cancer Center, have been elected fellows of the American Association for the Advancement of Science (AAAS).
This honor ranks among the highest distinctions in the scientific research community. Since 1874, AAAS has recognized leading scientists who...
New biomarker may guide best use of KRAS inhibitors in lung cancer
Lung cancer patients with high TTF-1 expression had improved survival outcomes following treatment with the KRAS inhibitor, sotorasib...
MD Anderson breaks ground on new Sugar Land location
The University of Texas MD Anderson Cancer Center today broke ground on a new 470,000-square-foot facility in Sugar Land, bringing a range...
MD Anderson Research Highlights for January 22, 2025
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
Novel allogeneic NK cell therapy from induced pluripotent stem cells shows encouraging efficacy in...
Jennifer Bickel, M.D., named MD Anderson Vice President and Chief Wellness Officer
The University of Texas MD Anderson Cancer Center today announced the selection of Jennifer Bickel, M.D., as the institution’s inaugural vice...
MD Anderson expands arts experience program to enhance healing and well-being for patients
As part of its ongoing commitment to patient comfort and healing, The University of Texas MD Anderson Cancer Center today announced a new...